Register and check the whole edition on the following link: https://economiadelasalud.com/wp-content/uploads/2020/11/EDS-Vol15N04.pdf.
Its now available the 4th edition of EDS Journal cotaining several articles about latest actuality. To highlight, there is an interesting entry about how to assess clinical benefit in order to accelerate access of innovative drugs where multidisciplinar experts have participated
Related Posts
-
Proud to be co-authors of a poster published in the official journal of the LXII National Congress of the Spanish Society of Haematology and Hemotherapy on the determination of the challenges and opportunities associated with platelet transfusion in the management of CLD-associated severe thrombocytopeniaProud to be co-authors of a poster published in the official journal of the LXII National Congress of the Spanish Society of Haematology and Hemotherapy on the determination of the challenges and opportunities associated with platelet transfusion in the management of CLD-associated severe thrombocytopenia
-
This week, from 20th to 22nd October, takes place the 65th National Congress of Spanish Society of Hospital Pharmacy, 100% online for the first time. This edition will include several chats about timeliness topics such as experiences about Horizon Scanning of Orphan Drugs and MCDA methodology that will be shared by Dr. Badía, CEO Omakase Consulting.This week, from 20th to 22nd October, takes place the 65th National Congress of Spanish Society of Hospital Pharmacy, 100% online for the first time. This edition will include several chats about timeliness topics such as experiences about Horizon Scanning of Orphan Drugs and MCDA methodology that will be shared by Dr. Badía, CEO Omakase Consulting.
Leave A Comment